Good day from #jakarta - been rather ansent these last few weeks. Just wanted yo say #hello and wishe everyone a #happyweekend. I’m recovering from the heavy side effects of #moderna #Spikevax we had to get in Singapore (Indonesia, please introduce a parallel private vaccine program - us foreigners are happy to pay a fee!). Felt rotten just like when I caught Covid in March 22. Been a week and my first coffee outing was rather exhausting- 😰. Anyroad, have a great day y’all!

The #CHMP also recommended to extend the use of #COVID19 vaccine #Spikevax 💉as a booster in children aged 6 to 11 years. ⬇️

#VaccinesWork

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-december-2022

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603711320376983556

The new bi-valent COVID-19 vaccine being called simply SpikeVax instead of something typically pharmaceutical is making my day. Also giving me the tingles. 💉 Actual tingles. Expect to sleep well later.
#spikevax #covid19

Vaccino bivalente #Spikevax. Aifa segnala casi di sottodosaggio accidentale della dose #booster

https://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=108862 via @QSanit@twitter.com

#JustPublished!
Joint @EMA_News and @ECDC_EU recommendations on use of recently authorised #COVID19 adapted vaccines.

Read the full statement here:
https://bit.ly/COVIDAdaptedBooster
#Omicron #BA1 #Comirnaty #Spikevax

🐦🔗: https://nitter.eu/ECDC_EU/status/1567139599230574594

RT @ECDC_EU: #JustPublished!
Joint @EMA_News and @ECDC_EU recommendations on use of recently authorised #COVID19 adapted vaccines.

Read the full statement here:
https://www.ecdc.europa.eu/en/news-events/covid-19-recommendations-use-adapted-vaccines
#Omicron #BA1 #Comirnaty #Spikevax

🐦🔗: https://nitter.eu/EMA_News/status/1567139778172157956

RT @ECDC_EU: #JustPublished!
Joint @EMA_News and @ECDC_EU recommendations on use of recently authorised #COVID19 adapted vaccines.

Read the full statement here:
https://www.ecdc.europa.eu/en/news-events/covid-19-recommendations-use-adapted-vaccines
#Omicron #BA1 #Comirnaty #Spikevax

🐦🔗: https://nitter.eu/EU_Health/status/1567139761915052035

RT @EMA_News: EMA has published #ClinicalData on the use of a #boosterdose of #Spikevax in adolescents aged 12 to 18 years old.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1564195913630982144

EMA has published #ClinicalData on the use of a #boosterdose of #Spikevax in adolescents aged 12 to 18 years old.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1564188212670652417

RT @EMA_News: EMA has published #ClinicalData on the use of a #boosterdose of #Spikevax in adolescents aged 12 to 18 years old.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1564192167811317764

EMA has published #ClinicalData supporting the extension of indication for #Spikevax in children between 6-11 years old. #COVID19
EMA & @GovCanHealth are the 1st regulatory authorities in the 🌍 to provide such access to clinical data.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1539604062777253891

EMA has published #ClinicalData supporting updated information for healthcare professionals on the use of a #boosterdose of #Spikevax in people who have already completed a primary vaccination series with any 🇪🇺authorised #COVID19vaccine .
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1537057082897321986

RT @EMA_News: EMA has published #ClinicalData supporting updated information for healthcare professionals on the use of a #boosterdose of #Spikevax in people who have already completed a primary vaccination series with any 🇪🇺authorised #COVID19vaccine .
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EEAthina/status/1537057128787202048

RT @EMA_News: EMA has published #ClinicalData supporting updated information for healthcare professionals on the use of a #boosterdose of #Spikevax in people who have already completed a primary vaccination series with any 🇪🇺authorised #COVID19vaccine .
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1537080194137214976

RT @EMA_News: #COVID19: EMA has published #ClinicalData supporting updated information for healthcare professionals on the efficacy of #Spikevax against the #Delta variant.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1535193185328275456

#COVID19: EMA has published #ClinicalData supporting updated information for healthcare professionals on the efficacy of #Spikevax against the #Delta variant.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1535170082531381249

We have started evaluating an application from Moderna to extend the use of #Spikevax to children from 6 months of age. This is the first application for this young age group. #EMAPresser #COVIDvaccines

🐦🔗: https://nitter.eu/EMA_News/status/1522194278059069440